Published in Acta Oncol on January 01, 1999
Imaging ovarian cancer and peritoneal metastases--current and emerging techniques. Nat Rev Clin Oncol (2010) 1.26
The impact of agricultural soil erosion on the global carbon cycle. Science (2007) 3.74
Targeting of iodine-123-labelled tumour-associated monoclonal antibodies to ovarian, breast, and gastrointestinal tumours. Lancet (1982) 2.51
A monoclonal antibody that detects HLA-D region antigen in routinely fixed, wax embedded sections of normal and neoplastic lymphoid tissues. J Clin Pathol (1985) 2.00
Right ventricular cardiomyopathy in beta-thalassaemia major. Eur Heart J (2002) 1.88
Imaging of tumor in patients with indium-111-labeled biotin and streptavidin-conjugated antibodies: preliminary communication. J Nucl Med (1990) 1.76
Use of two epithelium-specific monoclonal antibodies for diagnosis of malignancy in serous effusions. Lancet (1982) 1.76
Immune changes in patients with advanced breast cancer undergoing chemotherapy with taxanes. Br J Cancer (2002) 1.71
Limitations of radiolabeled monoclonal antibodies for localization of human neoplasms. Cancer Res (1986) 1.39
Alternative to toxicity and dosimetry of Y-90 labeled antibody. Int J Radiat Oncol Biol Phys (1989) 1.39
Specific localization and imaging of amyloid deposits in vivo using 123I-labeled serum amyloid P component. J Exp Med (1988) 1.34
E-cadherin expression in bladder cancer using formalin-fixed, paraffin-embedded tissues: correlation with histopathological grade, tumour stage and survival. Int J Cancer (1995) 1.25
Development of primary and secondary immune responses to mouse monoclonal antibodies used in the diagnosis and therapy of malignant neoplasms. Cancer Res (1986) 1.24
An immunohistological study of testicular germ cell tumours using two different monoclonal antibodies against placental alkaline phosphatase. Br J Cancer (1984) 1.19
Indium-111 labelled monoclonal antibody to placental alkaline phosphatase in in the detection of neoplasms of testis, ovary, and cervix. Lancet (1985) 1.17
A study of in vivo immune complex formation and clearance in man. J Immunol (1990) 1.14
Hypersensitivity reactions to carboplatin administration are common but not always severe: a 10-year experience. Oncology (2001) 1.12
Intraperitoneal radio-localization of tumors pre-targeted by biotinylated monoclonal antibodies. Int J Cancer (1990) 1.11
Antibody guided irradiation of brain glioma by arterial infusion of radioactive monoclonal antibody against epidermal growth factor receptor and blood group A antigen. Br Med J (Clin Res Ed) (1985) 1.11
Heavy metal contamination of roadside soils in the Greater Athens area. Environ Pollut (1987) 1.10
Exploiting altered glycosylation patterns in cancer: progress and challenges in diagnosis and therapy. Trends Biotechnol (1994) 1.08
Preexisting human anti-murine immunoglobulin reactivity due to polyclonal rheumatoid factors. Cancer Res (1987) 1.07
Development of anti-idiotypic antibodies against tumour antigens and autoantigens in ovarian cancer patients treated intraperitoneally with mouse monoclonal antibodies. Lancet (1988) 1.07
Antibody guided lymphangiography in the staging of cervical cancer. Br J Cancer (1985) 1.04
Phase II study of liposomal cisplatin (Lipoplatin) plus gemcitabine versus cisplatin plus gemcitabine as first line treatment in inoperable (stage IIIB/IV) non-small cell lung cancer. Lung Cancer (2009) 1.01
Inguinal swelling: a rare presentation of retroperitoneal hydatidosis. Eur J Surg (1999) 1.00
Elevated expression of the interleukin 4 receptor in carcinoma: a target for immunotherapy? Br J Cancer (1989) 1.00
Intraperitoneal 131I- and 90Y-labelled monoclonal antibodies for ovarian cancer: pharmacokinetics and normal tissue dosimetry. Int J Cancer Suppl (1988) 0.98
Site-specific polysialylation of an antitumor single-chain Fv fragment. Bioconjug Chem (2009) 0.97
Adjuvant therapy of ovarian cancer with radioactive monoclonal antibody. Br J Cancer (1993) 0.97
Oxaliplatin plus high-dose leucovorin and 5-fluorouracil in pretreated advanced breast cancer: a phase II study. Ann Oncol (2003) 0.96
Evaluation and selection of indicators for land degradation and desertification monitoring: methodological approach. Environ Manage (2014) 0.95
Palliative gastrectomy and other factors affecting overall survival in stage IV gastric adenocarcinoma patients receiving chemotherapy: a retrospective analysis. Eur J Surg Oncol (2011) 0.95
A comparative study of intraperitoneal carboplatin versus intravenous carboplatin with intravenous cyclophosphamide in both arms as initial chemotherapy for stage III ovarian cancer. Oncology (1999) 0.95
Salvage chemotherapy in anthracycline-pretreated metastatic breast cancer patients with docetaxel and gemcitabine: a multicenter phase II trial. Greek Breast Cancer Cooperative Group. Ann Oncol (1999) 0.95
Evaluation and selection of indicators for land degradation and desertification monitoring: types of degradation, causes, and implications for management. Environ Manage (2013) 0.95
Detection of human cancer in an animal model using radio-labelled tumour-associated monoclonal antibodies. Br J Cancer (1982) 0.94
EGFR, HER-2 and COX-2 levels in colorectal cancer. Histopathology (2008) 0.94
Monoclonal antibody assay of serum placental alkaline phosphatase in the monitoring of testicular tumours. Br J Cancer (1985) 0.93
Macrocyclic chelates of radiometals for diagnosis and therapy. Br J Cancer Suppl (1990) 0.93
Antibody guided targeting of non-small cell lung cancer using 111In-labeled HMFG1 F(ab')2 fragments. Cancer Res (1988) 0.92
Serious complications of tuberculous epididymitis. Infection (2000) 0.92
Development of humoral immune responses against a macrocyclic chelating agent (DOTA) in cancer patients receiving radioimmunoconjugates for imaging and therapy. Cancer Res (1992) 0.91
Antibody directed enzyme prodrug therapy (ADEPT): a review of the experimental and clinical considerations. Anticancer Res (1999) 0.91
Enhancement of monoclonal antibody uptake in human colon tumor xenografts following irradiation. Cancer Res (1990) 0.90
Quantitative measurement of monoclonal antibody distribution and blood flow using positron emission tomography and 124iodine in patients with breast cancer. Int J Cancer (1991) 0.90
Monoclonal antibodies for imaging and therapy. Br J Cancer (1989) 0.90
CEA and CA-19.9 serum tumor markers as prognostic factors in patients with locally advanced (unresectable) or metastatic pancreatic adenocarcinoma: a retrospective analysis. J Chemother (2009) 0.89
Tumour localisation with a radioactively labelled reshaped human monoclonal antibody. Br J Cancer (1991) 0.89
Imaging of metastatic melanoma utilising a technetium-99m labelled RGD-containing synthetic peptide. Eur J Nucl Med (1998) 0.89
Ovarian cancer: diagnosis using 123I monoclonal antibody in comparison with surgical findings. Nucl Med Commun (1984) 0.89
Antibody-guided radiolocalisation of tumours in patients with testicular or ovarian cancer using two radioiodinated monoclonal antibodies to placental alkaline phosphatase. Br J Radiol (1986) 0.88
Clonal T-large granular lymphocyte proliferations associated with clonal B cell lymphoproliferative disorders: report of eight cases. Leukemia (2002) 0.88
Redesigned anti-human placental alkaline phosphatase single-chain Fv: soluble expression, characterization and in vivo tumour targeting. Protein Eng (1997) 0.88
Effect of tumour necrosis factor on the uptake of specific and control monoclonal antibodies in a human tumour xenograft model. Br J Cancer (1995) 0.88
Localization of monoclonal antibody AUA1 and its F(ab')2 fragments in human tumour xenografts: an autoradiographic and immunohistochemical study. Int J Cancer Suppl (1988) 0.87
Radioimmunodiagnosis of ovarian cancer using 123I-labelled, tumor-associated monoclonal antibodies. Cancer Detect Prev (1984) 0.87
Radioimmunotherapy after chemotherapy compared to chemotherapy alone in the treatment of advanced ovarian cancer: a matched analysis. Oncol Rep (1998) 0.87
Effect of polarity and differentiation on antibody localization in multicellular tumour spheroid and xenograft models and its potential importance for in vivo immunotargeting. Int J Cancer (1989) 0.87
Applications of monoclonal antibodies in clinical oncology. Immunol Today (1994) 0.87
A recombinant single chain antibody interleukin-2 fusion protein. Br J Cancer (1993) 0.86
A new immunoassay using monoclonal antibodies HMFG1 and HMFG2 together with an existing marker CA125 for the serological detection and management of epithelial ovarian cancer. Br J Cancer (1986) 0.86
In vitro cytotoxicity following specific activation of amygdalin by beta-glucosidase conjugated to a bladder cancer-associated monoclonal antibody. Int J Cancer (1998) 0.85
A randomized trial comparing adjuvant fluorouracil, epirubicin, and mitomycin with no treatment in operable gastric cancer. Chemotherapy (1997) 0.85
A feasibility study of 1-h paclitaxel infusion in patients with solid tumors. Cancer Chemother Pharmacol (1997) 0.85
Intraperitoneal radioimmunotherapy for ovarian cancer. Br J Obstet Gynaecol (1989) 0.85
A low pH enzyme linked immunoassay using two monoclonal antibodies for the serological detection and monitoring of breast cancer. Br J Cancer (1986) 0.85
Molecular insights into the immunopathogenesis of follicular lymphoma. Immunol Today (2000) 0.83
Localization of biotinylated monoclonal antibody in nude mice bearing subcutaneous and intraperitoneal human tumour xenografts. Int J Cancer Suppl (1988) 0.83
XBONE: a hybrid expert system for supporting diagnosis of bone diseases. Stud Health Technol Inform (1997) 0.83
Characterisation and internalisation of recombinant humanised HMFG-1 antibodies against MUC1. Br J Cancer (2005) 0.83
Evaluation of TATI and CYFRA 21-1 in patients with head and neck squamous cell carcinoma. ORL J Otorhinolaryngol Relat Spec (1997) 0.83
Anaplastic lymphoma kinase (ALK) positive inflammatory pseudotumor of the liver: conservative treatment and long-term follow-up. Eur J Pediatr Surg (2010) 0.83
Radioimmunodetection of Cancer. Eur J Cancer Clin Oncol (1982) 0.83
Euthyroid sick syndrome in acute ischemic syndromes. Angiology (2002) 0.83
Two different schedules of irinotecan (CPT-11) in patients with advanced colorectal carcinoma relapsing after a 5-fluorouracil and leucovorin combination. A randomized study. Cancer Chemother Pharmacol (2003) 0.83
Evidence for immunoglobulin heavy chain variable region gene replacement in a patient with B cell chronic lymphocytic leukemia. Leukemia (1996) 0.83
Tumour-associated monoclonal antibodies for the diagnosis and assessment of ovarian cancer. Br J Obstet Gynaecol (1987) 0.83
Construction, characterisation and kinetics of a single chain antibody recognising the tumour associated antigen placental alkaline phosphatase. Br J Cancer (1993) 0.82
High intensity, interval exercise improves quality of life of patients with chronic heart failure: a randomized controlled trial. QJM (2013) 0.82
Enhancement by gamma-interferon of in vivo tumor radiolocalization by a monoclonal antibody against HLA-DR antigen. Cancer Res (1986) 0.81
Follicular lymphoma immunoglobulin kappa light chains are affected by the antigen selection process, but to a lesser degree than their partner heavy chains. Br J Haematol (1997) 0.81
Virtual endoscopy in the diagnosis of an adult double tracheal bronchi case. Eur J Radiol (2001) 0.81
5-fluorouracil cardiotoxicity is a rare, dose and schedule-dependent adverse event: a prospective study. J BUON (2007) 0.81
Scintigraphic imaging of sarcomatous tumors with [(111)In-DTPA-phe-1]-octreotide. Oncology (2000) 0.81
Genetic delivery of enzymes for cancer therapy. Gene Ther (1995) 0.81
5-Fluorouracil, epirubicin, and mitomycin C versus 5-fluorouracil, epirubicin, mitomycin C, and leucovorin in advanced gastric carcinoma. A randomized trial. Am J Clin Oncol (1996) 0.81
123I radioiodinated antibody imaging of occult ovarian cancer. Cancer (1985) 0.81
Thermodynamics of water and ethanol adsorption on four starches as model biomass separation systems. Biotechnol Bioeng (1984) 0.81
Tumour imaging using an improved method of DTPA-coupled monoclonal antibodies radiolabelled with metallic radionuclides. Lancet (1984) 0.81
Fibrin glue for sealing the needle track in fine-needle percutaneous lung biopsy using a coaxial system: Part II--Clinical study. Cardiovasc Intervent Radiol (1996) 0.80
Antibody-guided irradiation of malignant ascites in ovarian cancer: a new therapeutic method possessing specificity against cancer cells. Obstet Gynecol (1986) 0.80
Full dose paclitaxel plus vinorelbine as salvage chemotherapy in anthracycline-resistant advanced breast cancer: a phase II study. J Chemother (2003) 0.80
Immunolocalisation of testicular tumours using radiolabelled monoclonal antibody to placental alkaline phosphatase. J Nucl Med Allied Sci (1991) 0.80
An experimental approach of the Doppler perfusion index of the liver in detecting occult hepatic metastases: histological findings related to the hemodynamic measurements in Wistar rats. Eur Radiol (2000) 0.80
Molecular analysis of bcl-1/IgH junctional sequences in mantle cell lymphoma: potential mechanism of the t(11;14) chromosomal translocation. Br J Haematol (1999) 0.80
Evaluation of nasal mucociliary clearance after medical or surgical treatment of chronic rhinosinusitis. Eur Arch Otorhinolaryngol (2009) 0.80